Recruiting NA Cataract

New treatment option for Cataract

Official title Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality

ClinicalTrials.gov ID: NCT06624826

What this study is testing

What it's testing
Comparison of the visual performance of a refractive extended depth of focus intraocular lens in an emmetropic or monovision modality
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 105

You may be able to join if

  • Age-related bilateral cataract
  • Age 21 or older
  • Visual acuity \> 0.05
  • Axial length: 21.00-27.00mm
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant

You likely can't join if

  • Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.)...
  • Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX)
  • Irregular astigmatism on corneal tomography
  • Pronounced dry eye disease
  • Previous ocular surgery or trauma
  • Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)
See the full eligibility criteria
Who can join
  • Age-related bilateral cataract
  • Age 21 or older
  • Visual acuity \> 0.05
  • Axial length: 21.00-27.00mm
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant
  • Written informed consent prior to surgery
What rules you out
  • Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.) precluding good post-operative visual acuity
  • Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX)
  • Irregular astigmatism on corneal tomography
  • Pronounced dry eye disease
  • Previous ocular surgery or trauma
  • Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)

The study team makes the final eligibility decision.

Where it's taking place

  • Vienna, Austria, Austria

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 105 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Vienna, Austria, Austria. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.